Vertex Pharmaceuticals, Inc. (VRTX)
436.95
-13.46
(-2.99%)
USD |
NASDAQ |
May 15, 16:00
436.52
-0.43
(-0.10%)
After-Hours: 05:56
Vertex Pharmaceuticals EPS Diluted (Quarterly) : 4.024 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.612 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Moderna, Inc. | -3.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.031B |
| Revenue (Quarterly) | 3.012B |
| Total Expenses (Quarterly) | 1.981B |
| Enterprise Value | 105.63B |
| Gross Profit Margin (Quarterly) | 86.96% |
| Profit Margin (Quarterly) | 34.24% |
| Earnings Yield | 3.86% |
| Operating Earnings Yield | 4.38% |
| Normalized Earnings Yield | 3.941 |